Severity of Dyskinesia and D3R Signaling Changes Induced by L-DOPA Treatment of Hemiparkinsonian Rats Are Features Inherent to the Treated Subjects

Presynaptic Control of [3H]-Glutamate Release by Dopamine Receptor Subtypes in the Rat Substantia Nigra. Central Role of D1 and D3 Receptors

(2019) Laura Jesús Briones-Lizardi et al.   NEUROSCIENCE

Influence of DRD1 and DRD3 Polymorphisms in the Occurrence of Motor Effects in Patients with Sporadic Parkinson’s Disease

(2019) Erinaldo Ubirajara Damasceno dos Santos et al.   NEUROMOLECULAR MEDICINE

Dopamine receptors: homomeric and heteromeric complexes in l-DOPA-induced dyskinesia

(2018) Oscar Solís et al.   JOURNAL OF NEURAL TRANSMISSION

MTOR Pathway-Based Discovery of Genetic Susceptibility to L-DOPA-Induced Dyskinesia in Parkinson’s Disease Patients

(2018) Núria Martín-Flores et al.   MOLECULAR NEUROBIOLOGY

Behavioral and cellular dopamine D 1 and D 3 receptor-mediated synergy: Implications for L-DOPA-induced dyskinesia

(2018) Kathryn Lanza et al.   NEUROPHARMACOLOGY

Cardinal Motor Features of Parkinson’s Disease Coexist with Peak-Dose Choreic-Type Drug-Induced Dyskinesia

(2018) Etienne Goubault et al.   Journal of Parkinsons Disease

Genetic Knockdown of mGluR5 in Striatal D1R-Containing Neurons Attenuates l-DOPA-Induced Dyskinesia in Aphakia Mice

(2018) José-Rubén García-Montes et al.   MOLECULAR NEUROBIOLOGY

Shp-2 knockdown preventsl-dopa-induced dyskinesia in a rat model of Parkinson's disease

(2016) Chiara Fiorentini et al.   MOVEMENT DISORDERS

A partial lesion model of Parkinson's disease in mice – Characterization of a 6-OHDA-induced medial forebrain bundle lesion

(2015) Jordi Boix et al.   BEHAVIOURAL BRAIN RESEARCH

Dopamine D3 Receptor Modulates l-DOPA-Induced Dyskinesia by Targeting D1 Receptor-Mediated Striatal Signaling

(2015) Oscar Solís et al.   CEREBRAL CORTEX

Dopaminergic denervation switches dopamine D3 receptor signaling and disrupts its Ca2+ dependent modulation by CaMKII and calmodulin in striatonigral projections of the rat

(2015) Arturo Avalos-Fuentes et al.   NEUROBIOLOGY OF DISEASE

Chronic levodopa treatment alters expression and function of dopamine D3 receptor in the MPTP/p mouse model of Parkinson’s disease

(2015) Samantha R. Cote et al.   NEUROSCIENCE LETTERS

Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease

(2015) Matthieu F. Bastide et al.   PROGRESS IN NEUROBIOLOGY

Overexpression of the dopamine D3 receptor in the rat dorsal striatum induces dyskinetic behaviors

(2014) Samantha R. Cote et al.   BEHAVIOURAL BRAIN RESEARCH

Stronger Dopamine D1 Receptor-Mediated Neurotransmission in Dyskinesia

(2014) Daniel Farré et al.   MOLECULAR NEUROBIOLOGY

Levodopa-induced dyskinesias are associated with transient down-regulation of cAMP and cGMP in the caudate-putamen of hemiparkinsonian rats: Reduced synthesis or increased catabolism?

(2014) Giuseppe Sancesario et al.   NEUROCHEMISTRY INTERNATIONAL

Persistent activation of the D1R/Shp-2/Erk1/2 pathway in l-DOPA-induced dyskinesia in the 6-hydroxy-dopamine rat model of Parkinson's disease

(2013) Chiara Fiorentini et al.   NEUROBIOLOGY OF DISEASE

Immediate-early gene expression in structures outside the basal ganglia is associated to l-DOPA-induced dyskinesia

(2013) Matthieu F. Bastide et al.   NEUROBIOLOGY OF DISEASE

Presynaptic CaMKIIα modulates dopamine D3 receptor activation in striatonigral terminals of the rat brain in a Ca2+ dependent manner

(2013) Arturo Avalos-Fuentes et al.   NEUROPHARMACOLOGY

Buspirone anti-dyskinetic effect is correlated with temporal normalization of dysregulated striatal DRD1 signalling in l-DOPA-treated rats

(2013) Garikoitz Azkona et al.   NEUROPHARMACOLOGY

Age at onset influences neurodegenerative processes underlying PD with levodopa-induced dyskinesias

(2013) Antonio Cerasa et al.   PARKINSONISM & RELATED DISORDERS

G olf Mutation Allows Parsing the Role of cAMP-Dependent and Extracellular Signal-Regulated Kinase-Dependent Signaling in L-3,4-Dihydroxyphenylalanine-Induced Dyskinesia

(2012) C. Alcacer et al.   JOURNAL OF NEUROSCIENCE

Regulation of polysynaptic subthalamonigral transmission by D2, D3and D4dopamine receptors in rat brain slices

(2012) Ke-Zhong Shen et al.   JOURNAL OF PHYSIOLOGY-LONDON

D3 dopamine receptors interact with dopamine D1 but not D4 receptors in the GABAergic terminals of the SNr of the rat

(2012) Refugio Cruz-Trujillo et al.   NEUROPHARMACOLOGY

In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to l-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels

(2011) Flora Mela et al.   NEUROBIOLOGY OF DISEASE

L-DOPA-Induced Dyskinesia and Abnormal Signaling in Striatal Medium Spiny Neurons: Focus on Dopamine D1 Receptor-Mediated Transmission

(2011) Michael Feyder et al.   Frontiers in Behavioral Neuroscience

Missing pieces in the Parkinson's disease puzzle

(2010) Jose A Obeso et al.   NATURE MEDICINE

l-DOPA-induced dyskinesia in hemiparkinsonian rats is associated with up-regulation of adenylyl cyclase type V/VI and increased GABA release in the substantia nigra reticulata

(2010) Claudia Rangel-Barajas et al.   NEUROBIOLOGY OF DISEASE

Evaluation of the D3 dopamine receptor selective agonist/partial agonist PG01042 on l-dopa dependent animal involuntary movements in rats

(2010) Lindsay R. Riddle et al.   NEUROPHARMACOLOGY

Classifying risk factors for dyskinesia in Parkinson’s disease

(2010) J.C. Sharma et al.   PARKINSONISM & RELATED DISORDERS

Evaluation of the D3 dopamine receptor selective antagonist PG01037 on l-dopa-dependent abnormal involuntary movements in rats

(2009) Rakesh Kumar et al.   NEUROPHARMACOLOGY

Evaluation of D2 and D3 dopamine receptor selective compounds on l-dopa-dependent abnormal involuntary movements in rats

(2009) Rakesh Kumar et al.   NEUROPHARMACOLOGY

The selective D3 receptor antagonist, S33084, improves parkinsonian-like motor dysfunction but does not affect l-DOPA-induced dyskinesia in 6-hydroxydopamine hemi-lesioned rats

(2009) Flora Mela et al.   NEUROPHARMACOLOGY

Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia

(2008) A. Munoz et al.   BRAIN

Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms

(2008) M. Giorgi et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Identification of Dopamine D1–D3Receptor Heteromers

(2008) Daniel Marcellino et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Reciprocal Regulation of Dopamine D1 and D3 Receptor Function and Trafficking by Heterodimerization

(2008) C. Fiorentini et al.   MOLECULAR PHARMACOLOGY

Levodopa-related motor complications-Phenomenology

(2008) Susan H. Fox et al.   MOVEMENT DISORDERS

Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease

(2008) Naomi P. Visanji et al.   NEUROBIOLOGY OF DISEASE

6-OHDA-induced hemiparkinsonism and chronic l-DOPA treatment increase dopamine D1-stimulated [3H]-GABA release and [3H]-cAMP production in substantia nigra pars reticulata of the rat

(2008) Claudia Rangel-Barajas et al.   NEUROPHARMACOLOGY

Priming for l-dopa-induced dyskinesia in Parkinson’s disease: A feature inherent to the treatment or the disease?

(2008) Agnès Nadjar et al.   PROGRESS IN NEUROBIOLOGY

Nonmotor symptoms as presenting complaints in Parkinson's disease: A clinicopathological study

(2007) Sean S. O'Sullivan et al.   MOVEMENT DISORDERS